Tekturna Tablet, Film Coated
Product Images NDC 70839-150

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tekturna (NDC 70839-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lxo Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Tek00 0010 01)

Chemical structure diagram of aliskiren hemifumarate, the active ingredient in Tekturna, depicted with atoms and bonds representing its molecular configuration.*

FDA Label Image

Figure 1 (Tek00 0010 02)

A chart illustrating the impact of co-administered drugs on the pharmacokinetics of aliskiren. It displays fold changes and 90% confidence intervals in Cmax and AUC for various interacting drugs including CYP3A4/P-gp inhibitors, antihypertensives, and other drugs, with corresponding recommendations for dose adjustment or avoidance.*

FDA Label Image

Figure 2 (Tek00 0010 03)

A pharmacokinetic chart showing the fold change and 90% confidence intervals for the area under the curve (AUC) and maximum concentration (Cmax) of aliskiren when co-administered with various drugs including antihypertensives (e.g., hydrochlorthiazide, ramipril, amlodipine), others (e.g., digoxin, metformin, atorvastatin), and warfarin. The chart indicates 'No dose adjustment' recommendations for all listed drugs, comparing fold changes relative to aliskiren alone.*

FDA Label Image

Principal Display Panel (Package Label – 150 mg Bottle Label)

Label for Tekturna (aliskiren) 150 mg film-coated tablets, containing 30 tablets. The label shows the proprietary name Tekturna, the generic name aliskiren, strength 150 mg in bold, and manufacturer Noden Pharma. Directions indicate Rx only with storage instructions and manufacturer details from NODEN PHARMA USA INC.*

FDA Label Image

Principal Display Panel (Package Label – 150 mg Bottle Label)

Packaging label for Tekturna (aliskiren) tablets, 150 mg strength, oral film-coated tablets. The label indicates a package containing 30 tablets. It shows the NDC number 70839-150-30 and features the NODEN PHARMA logo. Manufactured by Novartis Pharma Produktions GmbH and distributed by NODEN PHARMA USA Inc.*

FDA Label Image

Principal Display Panel (Package Label – 300 mg Bottle Label)

Label for Tekturna 300 mg film-coated tablets containing aliskiren. The label shows the product name, active ingredient, strength, dosage form, and quantity of 30 tablets. It includes the NDC number 70839-300-30, manufacturer information for NODEN PHARMA USA INC, and storage instructions.*

FDA Label Image

Principal Display Panel (Package Label – 300 mg Bottle Label)

Label for Tekturna (aliskiren) Tablets, 300 mg strength, with a package size of 30 tablets. The film-coated oral tablets are labeled for Rx only. The label shows the NDC number 70839-300-30 and is distributed by NODEN PHARMA and LXO US Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.